Who invested in Apertura Gene Therapy?
Apertura Gene Therapy's investors include Deerfield.

United Kingdom · Series A startup
Funding summaryUpdated 26 Oct 2026
$67Mraised across 1 round since 2022, from 1 source
Apertura Gene Therapy's investors include Deerfield.
Apertura Gene Therapy has raised $67M across 1 round since 2022.
Apertura Gene Therapy's most recent round was a Series A of $67M in Apr 2022.
Its most recent round, $67M in Apr 2022, is also its largest on record.
Apertura Gene Therapy's first round on record, in Apr 2022, was backed by Deerfield.
Apertura Gene Therapy's latest named round is a Series A, in Apr 2022.
Apertura Gene Therapy is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.